[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
[Notices]
[Page 75670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-30784]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; Fisher 
Clinical Services,Inc.

    By Notice dated September 20, 2012, and published in the Federal 
Register on October 2, 2012, 77 FR 60143, Fisher Clinical Services, 
Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of noroxymorphone (9668), a basic class of 
controlled substance in schedule II.
    The company plans to import the listed substances for analytical 
research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Fisher Clinical Services, Inc., to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Fisher Clinical Services, Inc., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems; verification of the company's compliance 
with state and local laws; and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-30784 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P